Saladaga, Roselyn M.
HRN: 10-15-46 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/01/2022
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
11/01/2022
11/07/2022
IV
750mg
OD
CAP-HR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes